UPDATE 1-J&J's Janssen hit with $70 mln verdict in Risperdal trial
July 01, 2016 at 18:19 PM EDT
NEW YORK, July 1 (Reuters) - A U.S. jury on Friday awarded $70 million to the family of a boy who developed breasts after taking Johnson & Johnson unit Janssen Pharmaceuticals' antipsychotic drug Risperdal.
